Tig Advisors, LLC Abb Vie Inc. Transaction History

Tig Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $8.82 Million - $10.3 Million	-102,643 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $9.09 Million - $12.2 Million	-123,879 Reduced 54.69%	102,643 $10.1 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $14.4 Million - $21.8 Million	223,131 Added 6580.09%	226,522 $17.3 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $9.45 Million - $11.8 Million	-131,009 Reduced 97.48%	3,391 $300,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $8.46 Million - $10.2 Million	134,400 New	134,400 $10.2 Million

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tig Advisors, LLC with notifications on news.